Production, characteristics and mode of action of hemopoietic growth inhibitors in myeloid leukemias Inge OlssonTor Olofsson Editorial Pages: 1 - 6
Complete remissions in non small cell lung cancer J. KlasterskyJ. P. SculierP. Mommen Articles Pages: 11 - 15
Treatment of acute myelogenous leukemia in children G. SchellongU. CreutzigJ. Ritter Articles Pages: 17 - 25
Sequential methotrexate (MTX) and 5-fluorouracil (FU) in human tumor xenografts K. WayssR. HerrmannM. Volm Articles Pages: 27 - 32
Cytogenetical changes during early stages of development of methotrexate resistance in HeLa cells J. G. DelinassiosM. J. Talieri Articles Pages: 33 - 38
Effects of cytosine arabinoside on DNA synthesis and mitotic activity of HL-60 cells A. RazaS. C. ZhaoH. D. Preisler Articles Pages: 39 - 46
Intrahepatic and intravenous administration of adriamycin—A Comparative pharmacokinetic study in patients with malignant liver tumours Staffan EksborgBjörn J. CedermarkHanna-Sara Strandler Articles Pages: 47 - 54
Fourth Annual Sanrocco International Cancer Symposium Peter ReizensteinJohn McLarenClaudio Ogier Meeting Report Pages: 55 - 57
“Helper” and “suppressor” T lymphocytes regulating blood cell formation in man P. R. Notes Pages: 61 - 61
Relationship between plasma adriamycin levels and the outcome of remission induction therapy for acute nonlymphatic leukemia P. R. Notes Pages: 61 - 61
Cyclosporin a (Csp) — An immunosuppressive drug specific for T-helper cells? P. R. Notes Pages: 63 - 63
Interferon induces expression of HLA-DR and Fc-gamma-receptor for monomeric IgG1 P. R. Notes Pages: 64 - 64
Carbohydrates, lymphokines, and tumor inducing and tumor derived factors affect NK-cell activity P. R. Notes Pages: 65 - 65
European Society for Medical Oncology (ESMO) award for outstanding research in the field of medical oncology Announcement Pages: 67 - 67
